Published in J Exp Med on October 01, 1966
Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A (1969) 7.69
Studies of genetic transmission of murine leukemia virus by AKR mice. I. Crosses with Fv-1 n strains of mice. J Exp Med (1972) 6.52
The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome. J Exp Med (1971) 6.06
A novel murine oncornavirus with dual eco- and xenotropic properties. Proc Natl Acad Sci U S A (1975) 5.91
A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum. Proc Natl Acad Sci U S A (1973) 4.55
Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice. Proc Natl Acad Sci U S A (1976) 4.52
Structural proteins of mammalian oncogenic RNA viruses: multiple antigenic determinants of the major internal protein and envelope glycoprotein. J Virol (1974) 3.91
Further implication of murine leukemia-like virs in the disorders of NZB mice. J Exp Med (1969) 3.87
The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med (1974) 3.53
Biochemical evidence linking the GIX thymocyte surface antigen to the gp69/71 envelope glycoprotein of murine leukemia virus. J Exp Med (1975) 3.31
The murine leukemia-sarcoma virus complex. Proc Natl Acad Sci U S A (1967) 3.24
Relation of GIX antigen of thymocytes to envelope glycoprotein of murine leukemia virus. J Exp Med (1975) 3.06
A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J Virol (1990) 3.00
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. II. Mammalian leukemia-sarcoma viruses. J Virol (1972) 2.84
Biological and serological properties of viral particles from a nonproducer rat neoplasm induced by murine sarcoma virus (Moloney). J Virol (1968) 2.77
G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A (1970) 2.77
Host-gene control of C-type RNA tumor virus: inheritance of the group-specific antigen of murine leukemia virus. Proc Natl Acad Sci U S A (1971) 2.65
The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proc Natl Acad Sci U S A (1972) 2.54
Wild-type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice. J Exp Med (1971) 2.41
Evidence for recombination between N- and B-tropic murine leukemia viruses. J Virol (1977) 2.20
Some structural and antigenic properties of intracisternal A particles occurring in mouse tumors (complement fixation-immunodiffusion-neuroblastoma-plasma-cell tumor). Proc Natl Acad Sci U S A (1972) 2.19
Age-related changes in cell surface antigens of preleukemic AKR thymocytes. J Exp Med (1976) 2.15
Radioimmunoassay of mammalian type C viral proteins. 3. Detection of viral antigen in normal murine cells and tissues. J Exp Med (1973) 2.13
Induction of GIX antigen and gross cell surface antigen after infection by ecotropic and xenotropic murine leukemia viruses in vitro. J Virol (1976) 2.11
A classification of the murine leukemia viruses. Neutralization of pseudotypes of Friend spleen focus-forming virus by type-specific murine antisera. J Exp Med (1972) 1.92
Hamster-tropic sarcomagenic and nonsarcomagenic viruses derived from hamster tumors induced by the Gross pseudotype of Moloney sarcoma virus. Proc Natl Acad Sci U S A (1970) 1.71
Characterization of molecular species carrying gross cell surface antigen. J Virol (1977) 1.69
Expression of murine leukemia virus envelope glycoprotein gp69/71 on mouse thymocytes. Evidence for two structural variants distinguished by presence vs. absence of GIX antigen. J Exp Med (1975) 1.62
Viral and cellular surface antigens of murine leukemias and myelomas. Serological analysis by immunoelectron microscopy. J Exp Med (1972) 1.62
Identification of the Gross cell surface antigen associated with murine leukemia virus-infected cells. J Virol (1977) 1.54
Expression of endogenous RNA C-type virus group-specific antigens in mammalian cells. J Virol (1973) 1.45
Serological and structural properties of Mason-Pfizer monkey virus isolated from the mammary tumor of a Rhesus monkey. Proc Natl Acad Sci U S A (1971) 1.43
Chromatographic Separation and Antigenic Analysis of Proteins of the Oncornaviruses IV. Biochemical Typing of Murine Viral Proteins. J Virol (1975) 1.41
Antigenic properties of endogenous type-C viruses from spontaneously transformed clones of BALB-3T3. Proc Natl Acad Sci U S A (1973) 1.36
Wild-type gross leukemia virus: classification of soluble antigens (GSA). J Virol (1972) 1.31
Antigenic components of group A arbovirus virions. J Virol (1973) 1.30
Relation of chromosome 4 (linkage group 8) to murine leukemia virus-associated antigens of AKR mice. J Exp Med (1973) 1.27
Virus-specific antigens in hamster cells transformed by Rous sarcoma virus. J Virol (1970) 1.23
Common cell-surface antigen associated with murine and feline C-type RNA leukemia viruses. Proc Natl Acad Sci U S A (1973) 1.20
An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells. Proc Natl Acad Sci U S A (2002) 1.19
Relationship of infectious murine leukemia virus and virus-related antigens in genetic crosses between AKR and the Fv-1 compatible strain C57L. J Exp Med (1976) 1.18
Antigen related to mammalian type-C RNA viral p30 proteins is located in renal glomeruli in human systemic lupus erythematosus. Proc Natl Acad Sci U S A (1976) 1.18
Activation and isolation of hamster-specific C-type RNA viruses from tumors induced by cell cultures transformed by chemical carcinogens. Proc Natl Acad Sci U S A (1971) 1.18
Expression of fetal antigens in tumor cells. Proc Natl Acad Sci U S A (1972) 1.16
G(RADA1): a new cell surface antigen of mouse leukemia defined by naturally occurring antibody and its relationship to murine leukemia virus. J Exp Med (1978) 1.15
New cell surface antigens in rat defined by tumors of the nervous system. Proc Natl Acad Sci U S A (1975) 1.15
Heredity of the GIX thymocyte antigen associated with murine leukemia virus: segregation data simulating genetic linkage. Proc Natl Acad Sci U S A (1976) 1.13
X-gp70: a third molecular species of the envelope protein gp70 of murine leukemia virus, expressed on mouse lymphoid cells. J Exp Med (1976) 1.12
Preleukemic expression of TL antigens in x-irradiated C57BL/6 mice. J Exp Med (1977) 1.10
Serum-mediated leukemia cell destruction in AKR mice. J Exp Med (1973) 1.08
Two species of type C viral core polyprotein on AKR mouse leukemia cells. J Virol (1977) 1.08
Cell surface antigens associated with murine leukemia virus: definition of the GL and GT antigenic systems. J Virol (1973) 1.05
Multiple group-specific antigen components of avian tumor viruses detected with chicken and hamster sera. J Virol (1969) 1.02
Species and interspecies radioimmunoassays for rat type C virus p30: interviral comparisons and assay of human tumor extracts. J Virol (1975) 1.00
Monoclonal antibodies identify individual determinants on mouse mammary tumor virus glycoprotein gp52 with group, class, or type specificity. J Virol (1980) 0.98
The detection of a spleen focus-forming virus neoantigen by lymphocyte-mediated cytolysis. J Exp Med (1978) 0.98
In vitro production of mouse mammary tumor virus in a mouse mammary tumor ascites line. Proc Natl Acad Sci U S A (1973) 0.94
Induction of partial immunologic tolerance in rats and progressive loss of cellular antigenicity in Gross virus lymphoma. J Exp Med (1974) 0.90
Induction of antibody response to liposome-associated Gross-virus cell-surface antigen (GCSAa). Br J Cancer (1980) 0.89
Spontaneous induction of endogenous murine leukemia virus-related antigen expression during short-term in vitro incubation of mouse lymphocytes. Proc Natl Acad Sci U S A (1974) 0.89
Absence of leukosis virus markers in hamster cells transformed by herpes simplex virus type 2. J Virol (1972) 0.89
Genetic analysis of Gv1, a gene controlling transcription of endogenous murine polytropic proviruses. J Virol (1999) 0.88
Association of gross virus-associated cell-surface antigen with liposomes. Br J Cancer (1980) 0.86
Type C RNA virus-specific antibody in human systemic lupus erythematosus demonstrated by enzymoimmunoassay. Proc Natl Acad Sci U S A (1978) 0.85
An anti-mouse macrophage monoclonal antibody reacting with T-derived leukaemic cells. Immunology (1984) 0.85
Antigenic relationship between the herpesviruses of infectious bovine rhinotracheitis, Marek's disease, and Burkitt's lymphoma. J Virol (1972) 0.85
Presentation of an MuLV-related tumour antigen in liposomes as a potent tertiary immunogen after adoptive transfer. Immunology (1986) 0.85
Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity. Br J Cancer (1975) 0.83
Detection of a tumour-specific antigen (Gross) with the mixed antiglobulin reaction using erythrocytes from NZB-B1 mice. Immunology (1968) 0.82
Characterization of a new tissue-specific transcription factor binding to the simian virus 40 enhancer TC-II (NF-kappa B) element. Mol Cell Biol (1992) 0.82
Immunohistologic detection of antigen related to primate type C retrovirus p30 in normal human placentas. Am J Pathol (1983) 0.81
Propagation of rat parvovirus in thymic lymphoma cell line C58(NT)d and subsequent appearance of a resistant cell clone after lytic infection. J Virol (2001) 0.81
Radioimmunoassay for intact Gross mouse leukemia virus. Proc Natl Acad Sci U S A (1976) 0.81
Immunological cross-reactions between two low-molecular-weight polypeptides from a murine type C virus. J Virol (1974) 0.81
Detection and immunochemical characterization of a primate type C retrovirus-related p30 protein in normal human placentas. Proc Natl Acad Sci U S A (1984) 0.81
Studies on mouse Moloney virus induced tumours: II. Detection of p30 in the serum of mice with Moloney leukaemia by in vitro blocking of complement dependent antibody mediated cytotoxicity. Br J Cancer (1975) 0.79
Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation. Br J Cancer (1974) 0.78
Nucleotide sequence of a cDNA encoding the rat T3 delta chain. Nucleic Acids Res (1990) 0.78
Activating and protective capacities of a purified electrophoretic fraction of murine leukemia virus for murine leukemia virus infectivity. Proc Natl Acad Sci U S A (1972) 0.78
Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes. J Exp Med (1974) 0.78
Serum antibody reacting with placental syncytiotrophoblast in sera of patients with autoimmune diseases--a possible relation to type C RNA retrovirus. Clin Exp Immunol (1985) 0.77
Expression of the major internal viral polypeptide in cells transformed by wild-type and temperature-sensitive murine sarcoma virus. J Virol (1974) 0.75
Measurement of Gross cell-surface antigen and p30 level in murine retrovirus-infected cell lines. Br J Cancer (1981) 0.75
Counter-immunoelectrophoresis: rapid method for detecting group-specific antigen and antibodies associated with oncogenic ribonucleic acid viruses. Appl Microbiol (1971) 0.75
Surface antigens of mammalian sarcoma virus-transformed nonproducer cells. Proc Natl Acad Sci U S A (1974) 0.75
Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J Exp Med (1957) 12.19
A virus-induced disease of mice characterized by erythrocytopoiesis and lymphoid leukemia. J Natl Cancer Inst (1962) 5.44
Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations. J Natl Cancer Inst (1960) 5.28
Some further data on cytotoxic isoantibodies in the mouse. Ann N Y Acad Sci (1962) 4.59
TYPING OF MOUSE LEUKAEMIAS BY SEROLOGICAL METHODS. Nature (1964) 3.87
Antigens of tumors and leukemias induced by viruses. Fed Proc (1966) 3.43
Development and serial cellfree passage of a highly potent strain of mouse leukemia virus. Proc Soc Exp Biol Med (1957) 2.78
Cytotoxic and neutralization tests with serum and lymph node cells of isologous mice with induced resistance against gross lymphomas. Cancer Res (1962) 2.76
Induction of leukemia in rat by pulse doses of 7,12-dimethylbenz(a)anthracene. Proc Natl Acad Sci U S A (1966) 2.19
OCCURRENCE OF SOLUBLE ANTIGEN IN THE PLASMA OF MICE WITH VIRUS-INDUCED LEUKEMIA. Proc Natl Acad Sci U S A (1964) 1.48
COMPARISON OF TUMOUR ANTIGENS IN AKR AND GROSS VIRUS (PASSAGE A)-INDUCED LEUKAEMIAS. Nature (1965) 1.43
A highly inbred line of Wistar rats yielding spontaneous mammo-somatotropic pituitary and other tumors. J Natl Cancer Inst (1960) 1.38
EARLY AND LATE LEUKEMIAS IN RATS AFTER TRANSPLANTATION OF LEUKEMIC CELLS FROM AKR MICE. Cancer Res (1964) 1.30
An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42
Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J Exp Med (1975) 17.16
A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc Natl Acad Sci U S A (1977) 13.96
Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. J Exp Med (1975) 13.69
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature (2001) 11.03
Tumor necrosis factor (TNF). Science (1985) 8.80
Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse. Proc R Soc Lond B Biol Sci (1968) 7.51
Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells. J Exp Med (1975) 7.20
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci U S A (1979) 6.93
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A (1976) 6.82
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A (1998) 6.82
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A (1997) 6.67
The G (Gross) leukemia antigen. Cancer Res (1965) 6.07
The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome. J Exp Med (1971) 6.06
Control of mating preferences in mice by genes in the major histocompatibility complex. J Exp Med (1976) 5.52
A pseudogene homologous to mouse transplantation antigens: transplantation antigens are encoded by eight exons that correlate with protein domains. Cell (1981) 5.43
Regulation of cellular and humoral immune responses by T-cell subclasses. Cold Spring Harb Symp Quant Biol (1977) 5.21
Surface alloantigens of plasma cells. J Exp Med (1970) 5.19
T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells. J Exp Med (1976) 5.11
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med (1998) 5.06
Lymphocytes as models for the study of mammalian cellular differentiation. Immunol Rev (1977) 5.01
Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1980) 4.66
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med (1998) 4.65
Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro. J Exp Med (1968) 4.63
Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice. Proc Natl Acad Sci U S A (1976) 4.52
Ly antigens as markers for functionally distinct subpopulations of thymus-derived lymphocytes of the mouse. Nature (1975) 4.34
Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera. Proc Natl Acad Sci U S A (1979) 4.14
Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A (1989) 4.13
Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A (1997) 4.10
Serological analysis of cell surface antigens of malignant human brain tumors. Proc Natl Acad Sci U S A (1978) 3.99
Improved complementation in the cytotoxic test. Transplantation (1970) 3.93
Current enigmas in cancer research. Harvey Lect (1973) 3.91
Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. Proc Natl Acad Sci U S A (1983) 3.83
p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. Proc Natl Acad Sci U S A (1981) 3.72
Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture. Cancer Res (1981) 3.62
Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells. Proc Natl Acad Sci U S A (1982) 3.58
Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1966) 3.56
Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells. J Exp Med (1969) 3.53
Immunoglobulin and other surface antigens of cells of the immune system. J Exp Med (1971) 3.50
An approach to the mapping of antigens on the cell surface. Proc Natl Acad Sci U S A (1968) 3.46
Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med (1979) 3.43
Antigens of tumors and leukemias induced by viruses. Fed Proc (1966) 3.43
Ly-C: a third locus specifying alloantigens expressed only on thymocytes and lymphocytes. Transplantation (1971) 3.42
Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics. J Exp Med (1977) 3.42
Genetic linkage relationships of loci specifying differentiation alloantigens in the mouse. Transplantation (1972) 3.34
Biochemical evidence linking the GIX thymocyte surface antigen to the gp69/71 envelope glycoprotein of murine leukemia virus. J Exp Med (1975) 3.31
In-vitro demonstration of thymic hormone in the mouse by conversion of precursor cells into lymphocytes. Lancet (1973) 3.27
Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med (1982) 3.27
Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody. Proc Natl Acad Sci U S A (1967) 3.26
Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity (1994) 3.24
Detection of avian and mammalian oncogenic RNA viruses (oncornaviruses) by immunofluorescence. Cancer Res (1972) 3.23
Recognition among mice. Evidence from the use of a Y-maze differentially scented by congenic mice of different major histocompatibility types. J Exp Med (1979) 3.23
Isolation and some characteristics of a group-specific antigen of the murine leukemia viruses. Virology (1969) 3.21
Differentiation of T cells induced by preparations from thymus and by nonthymic agents. J Exp Med (1973) 3.12
Relation of GIX antigen of thymocytes to envelope glycoprotein of murine leukemia virus. J Exp Med (1975) 3.06
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci U S A (2000) 3.00
Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses. J Exp Med (1976) 2.99
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer (2001) 2.95
Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc Natl Acad Sci U S A (1986) 2.94
Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci U S A (1990) 2.91
Mouse isoantigens: separation of soluble TL (thymus-leukemia) antigen from soluble H-2 histocompatibility antigen by column chromatography. J Exp Med (1967) 2.86
Shared viral antigen of mammalian leukaemia viruses. Nature (1970) 2.84
Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity (2000) 2.81
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci U S A (2000) 2.79
Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc Natl Acad Sci U S A (1975) 2.77
G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A (1970) 2.77
GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J Exp Med (1982) 2.74
Immunogenetics of cell surface antigens of mouse leukemia. Annu Rev Genet (1977) 2.69
Distinctive urinary odors governed by the major histocompatibility locus of the mouse. Proc Natl Acad Sci U S A (1981) 2.68
Use of hybrid antibody with anti-gamma-G and anti-ferritin specificities in locating cell surface antigens by electron microscopy. J Exp Med (1968) 2.62
Detection of antibody to autologous human leukemia cells by immune adherence assays. Proc Natl Acad Sci U S A (1977) 2.59
Occurrence of natural antibody to the G (gross) leukemia antigen in mice. Cancer Res (1966) 2.57
T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures. Proc Natl Acad Sci U S A (1984) 2.54
Thymus cells of radiation-chimeras: TL phenotype, sensitivity to guinea-pig serum, and origin from donor cells. Nature (1965) 2.54
Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens. J Exp Med (1981) 2.53
Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci U S A (1999) 2.53
Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2. J Exp Med (1973) 2.52